Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has acquired Organon, a pharmacy business in New Jersey, for $11.75B. Organon operates in healthcare and develops and manufactures medicines across multiple therapeutic areas, supporting Sun Pharma’s product portfolio expansion. Sun Pharma acquisitions in pharmacy acquisition strategy aim to strengthen global distribution and deepen capabilities in branded and specialty products. The platform acquisition is a strategic acquisition by a public pharmaceutical buyer, classified as healthcare M&A, with an announced deal size around $12B. Closing is expected after customary regulatory approvals and definitive agreement terms.